Evaluation of the Efficacy and Safety of a Combination regimen of Bedaquiline, Delamanid, Linezolid and Clofazimine in Adults with Pre-extensive (Pre-XDR) and Extensively Drug-resistant Pulmonary Tuberculosis (XDR-TB):Prospective Cohort Study - BEAT study
Latest Information Update: 05 Jul 2022
At a glance
- Drugs Bedaquiline (Primary) ; Clofazimine (Primary) ; Delamanid (Primary) ; Linezolid (Primary)
- Indications Tuberculosis
- Focus Therapeutic Use
- Acronyms BEAT-India
Most Recent Events
- 05 Jul 2022 New trial record
- 29 Jun 2022 Results published in the Clinical Infectious Diseases